CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib
Abstract
Authors
J. Desai AJ. Wagner Garcia I. Carrasco M. Cesari M. Gordon CC. Lin Z. Papai CW. Ryan WD. Tap JC. Trent H. Gelderblom P. Grimison Pousa A. López Van. Tine D. Dai M. Rubinacci K. Tecson M. Wooddell S. Stacchiotti